SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 17.02 |
Enterprise Value ($M) | n/a |
Book Value ($M) | 7.79 |
Book Value / Share | 0.00 |
Price / Book | n/a |
NCAV ($M) | 7.67 |
NCAV / Share | 0.00 |
Price / NCAV | n/a |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -2.52 |
Return on Assets (ROA) | -0.89 |
Return on Equity (ROE) | -1.12 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 3.84 |
Current Ratio | 3.84 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 10.43 |
Assets | 10.55 |
Liabilities | 2.76 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 3.75 |
Operating Income | -19.88 |
Net Income | -19.12 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -12.61 |
Cash from Investing | -0.01 |
Cash from Financing | 9.22 |
(click for more detail) |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Similar Companies | |
---|---|
PLPL – Plandaí Biotechnology, Inc. | PPCB – Propanc Biopharma, Inc. |
PREDQ – Predictive Technology Group, Inc. | PROCF – Procaps Group S.A. |
PRRUF – Immutep Limited |
Financial data and stock pages provided by
Fintel.io